Trademark applications and grants for Regulus Therapeutics Inc.. Regulus Therapeutics Inc. has 18 trademark applications. The latest application filed is for "a symbol or image mark"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 4224 Campus Point Court, Suite 210 San Diego, CALIFORNIA UNITED STATES 92121 |
Patent Application | Date |
---|---|
METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE 20220213483 - 17/700339 ALLERSON; Charles R. ;   et al. | 2022-07-07 |
Methods for Oral Delivery of Oligonucleotides 20220098581 - 17/259366 Wright; Timothy | 2022-03-31 |
MicroRNA Compounds and Methods for Modulating MIR-10B Activity 20220096517 - 17/290298 Allerson; Charles R. | 2022-03-31 |
METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE 20220025372 - 17/494234 ANDROSAVICH; John R. ;   et al. | 2022-01-27 |
Galnac Conjugated Modified Oligonucleotides as MIR-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-Effect 20210170034 - 17/052333 Allerson; Charles R. ;   et al. | 2021-06-10 |
CAGE Code | 5M2K0 | REGULUS THERAPEUTICS INC. |
S.A.M. Registration | 5M2K0 [3702665] | REGULUS THERAPEUTICS INC. |
SEC | 0001505512 | Regulus Therapeutics Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.